Published in BMJ Open on August 12, 2015
Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome. Mol Cell Pediatr (2016) 0.94
Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med (2003) 7.51
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ (2008) 4.12
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2011) 3.54
Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr (2001) 1.32
Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics (2000) 1.30
Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: a pharmacokinetic study. Br J Clin Pharmacol (1984) 1.26
Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol (1998) 1.17
Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol (2010) 1.08
Central mechanisms of menthol-induced analgesia. J Pharmacol Exp Ther (2012) 1.05
Disposition kinetics and effects of menthol. Clin Pharmacol Ther (1999) 1.03
Gastrointestinal clinical pharmacology of peppermint oil. Phytomedicine (2005) 0.97
Menthol--pharmacology of an important naturally medicinal "cool". Mini Rev Med Chem (2013) 0.93
A phase I study evaluating tolerability, pharmacokinetics, and preliminary efficacy of L-menthol in upper gastrointestinal endoscopy. Clin Pharmacol Ther (2011) 0.93
Metabolic fate of [3H]-l-menthol in the rat. Drug Metab Dispos (1994) 0.88
CYP2A6 genotype but not age determines cotinine half-life in infants and children. Clin Pharmacol Ther (2013) 0.84
Magnet tracking allows assessment of regional gastrointestinal transit times in children. Clin Exp Gastroenterol (2013) 0.83
The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst. Drug Metab Dispos (2013) 0.82
Relationship of gastrointestinal symptoms and psychosocial distress to gastric retention in children. J Pediatr (2014) 0.81
An evidence-based systematic review of spearmint by the natural standard research collaboration. J Diet Suppl (2010) 0.79
Determination of menthol in plasma and urine of rats and humans by headspace solid phase microextraction and gas chromatography--mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.79
Metabolism of (+)- and (-)-menthols by CYP2A6 in human liver microsomes. J Oleo Sci (2011) 0.78
Pharmacokinetics of menthol and carvone after administration of an enteric coated formulation containing peppermint oil and caraway oil. Arzneimittelforschung (2001) 0.77